[en] During angiogenesis, endothelial cells use uPA and PAI-I to migrate and degrade the basement membrane surrounding capillary blood vessels. Invasive tumor cells produce a large amount of uPA that could bind uPAR present at the endothelial cell surface to facilitate their invasion. To verify this hypothesis, endothelial cells were incubated with conditioned medium (CM) from two breast cancer cell lines (MCF7 and MDA MB 231 cells). Within a short incubation period (30 min) with both CM, an increase of uPA, PAW and uPA-PAI-I complex was detected in endothelial cell layer as assessed by casein zymography, ELISA and uPA immunostaining. The extent of this enhancement was related to the levels of uPA secreted by tumor cells (high in MDA MB 231 cells and low in MCF7 cells). After 2 hr of incubation, the CM from both tumor cells upregulated uPA and PAI-I mRNA levels in endothelial cells in a time-dependent manner. The uPA increase in the cell layer could not be attributable to an increase of uPAR level. Only the CM from highly invasive MDA MB 231 cells increased the angiogenic morphotype of endothelial cells assessed in a collagen gel. A single addition of amino-terminal fragment of uPA (ATF) was able to abolish the angiogenic effect induced by MDA MB 231 cell CM. Our data demonstrate that the interactions occurring between breast tumor cells and endothelial cells can modulate tumor angiogenesis at least by two mechanisms: an increase of uPA and PAI-I cell surface-binding and of their expression by endothelial cells. (C) 2002 Wiley-Liss, Inc.
Disciplines :
Oncology
Author, co-author :
Bajou, Khalid ; Université de Liège - ULiège > Département des sciences de la vie > Biologie et génétique moléculaire
Lewalle, J. M.
Martinez, C. R.
Soria, C.
Lu, H.
Noël, Agnès ; Université de Liège - ULiège > Département des sciences biomédicales et précliniques > Biologie cellulaire et moléculaire appliquée à l'homme
Foidart, Jean-Michel ; Université de Liège - ULiège > Département des sciences cliniques > Gynécologie - Obstétrique
Language :
English
Title :
Human breast adenocarcinoma cell lines promote angiogenesis by providing cells with uPA-PAI-1 and by enhancing their expression
Publication date :
10 August 2002
Journal title :
International Journal of Cancer
ISSN :
0020-7136
eISSN :
1097-0215
Publisher :
Wiley Liss, Inc., New York, United States - New York
Weidner N., Semple J.P., Welch W.R., Folkman J. (1991) Tumor angiogenesis and metastasis - Correlation in invasive breast carcinoma. N Engl J Med 324:1-8.
Folkman J., Watson K., Ingber D., Hanahan D. (1989) Induction of angiogenesis during the transition from hyperplasia to neoplasia. Nature 339:58-61.
Folkman J. (1990) What is the evidence that tumors are angiogenesis dependent?. J Natl Cancer Inst 82:4-6.
Gualandris A., Lopez C.T., Giunciuglio D., Albini A., Sabini E., Rusnati M., Dell'Era P., Presta M. (1997) Urokinase-type plasminogen activator overexpression enhances the invasive capacity of endothelial cells. Microvasc Res 53:254-260.
Schnaper H.W., Barnathan E.S., Mazar A., Maheshwari S., Ellis S., Cortez S.L., Baricos W.H., Kleinman H.K. (1995) Plasminogen activators augment endothelial cell organization in vitro by two distinct pathways. J Cell Physiol 165:107-118.
Stump D.C., Lijnen H.R., Collen D. (1986) Purification and characterization of a novel low molecular weight form of single-chain urokinase-type plasminogen activator. J Biol Chem 261:17120-17126.
Andreasen P.A., Kjoller L., Christensen L., Duffy M.J. (1997) The urokinase-type plasminogen activator system in cancer metastasis: A review. Int J Cancer 72:1-22.
Dano K., Andreasen P.A., Grondahl-Hansen J., Kristensen P., Nielsen L.S., Skriver L. (1985) Plasminogen activators, tissue degradation, and cancer. Adv Cancer Res 44:139-266.
Schmitt M., Wilhelm O.G., Reuning U., Krüger A., Harbeck N., Lengyel E., Graeff H., Gänsbacher B., Kessler H., Bürgle M., Stürzebecher J., Sperl S., Magdolen V. (2000) The urokinase plasminogen activator system as a novel target for tumor therapy. Fibrinolysis Proteol 14:114-132.
Bajou K., Noel A., Gerard R.D., Masson V., Brunner N., Holst-Hansen C., Skobe M., Fusenig N.E., Carmeliet P., Collen D., Foidart J.M. (1998) Absence of host plasminogen activator inhibitor 1 prevents cancer invasion and vascularization. Nat Med 4:923-928.
Noel A., Bajou K., Masson V., Devy L., Frankenne F., Rakic J.M., Lambert V., Carmeliet P., Foidart J.M. (1999) Regulation of cancer invasion and vascularization by plasminogen activator inhibitor-1. Fibrinolysis Proteol 13:220-225.
Pepper M.S., Montesano R. (1990) Proteolytic balance and capillary morphogenesis. Cell Differ Dev 32:319-327.
Mignatti P., Rifkin D.B. (1996) Plasminogen activators and matrix metalloproteinases in angiogenesis. Enzyme Protein 49:117-137.
Vassalli J.D., Sappino A.P., Belin D. (1991) The plasminogen activator/plasmin system. J Clin Invest 88:1067-1072.
Saksela O., Rifkin D.B. (1988) Cell-associated plasminogen activation: Regulation and physiological functions. Annu Rev Cell Biol 4:93-126.
Kumar R., Yoneda J., Bucana C.D., Fidler I.J. (1998) Regulation of distinct steps of angiogenesis by different angiogenic molecules. Int J Oncol 12:749-757.
Jaffe E.A., Nachman R.L., Becker C.G., Minick C.R. (1973) Culture of human endothelial cells derived from umbilical veins. Identification by morphologic and immunologic criteria. J Clin Invest 52:2745-2756.
Putnins E.E., Firth J.D., Uitto V.J. (1995) Keratinocyte growth factor stimulation of gelatinase (matrix metalloproteinase-9) and plasminogen activator in histiotypic epithelial cell culture. J Invest Dermatol 104:989-994.
Leprince P., Rogister B., Moonen G.A. (1989) Colorimetric assay for the simultaneous measurement of plasminogen activators and plasminogen activator inhibitors in serum-free conditioned media from cultured cells. Anal Biochem 177:341-346.
Chomczynski P., Sacchi N. (1987) Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162:156-159.
Nelles L., Lijnen H.R., Collen D., Holmes W.E. (1987) Characterization of recombinant human single chain urokinase-type plasminogen activator mutants produced by site-specific mutagenesis of lysine 158. J Biol Chem 262:5682-5689.
Pannekoek H., Veerman H., Lambers H., Diergaarde P., Verweij C.L., Van Zonneveld A.J., Van Mourik J.A. (1986) Endothelial plasminogen activator inhibitor (PAI): A new member of the Serpin gene family. EMBO J 5:2539-2544.
Montesano R., Orci L. (1985) Tumor-promoting phorbol esters induce angiogenesis in vitro. Cell 42:469-477.
Lu H., Mabilat C., Yeh P., Guitton J.D., Li H., Pouchelet M., Shoevaert D., Legrand Y., Soria J., Soria C. (1996) Blockage of urokinase receptor reduces in vitro the motility and the deformability of endothelial cells. FEBS Lett 380:21-24.
Saksela O., Moscatelli D., Rifkin D.B. (1987) The opposing effects of basic fibroblast growth factor and transforming growth factor beta on the regulation of plasminogen activator activity in capillary endothelial cells. J Cell Biol 105:957-963.
Mignatti P., Mazzieri R., Rifkin D.B. (1991) Expression of the urokinase receptor in vascular endothelial cells is stimulated by basic fibroblast growth factor. J Cell Biol 113:1193-1201.
El Y.I., Boilly-Marer Y. (1995) Production of acidic and basic fibroblast growth factor by the hormone-independent breast cancer cell line MDA-MB-231. Anticancer Res 15:783-790.
Peverali F.A., Mandriota S.J., Ciana P., Marelli R., Quax P., Rifkin D.B., Della V.G., Mignatti P. (1994) Tumor cells secrete an angiogenic factor that stimulates basic fibroblast growth factor and urokinase expression in vascular endothelial cells. J Cell Physiol 161:1-14.
Pepper M.S., Sappino A.P., Stocklin R., Montesano R., Orci L., Vassalli J.D. (1993) Upregulation of urokinase receptor expression on migrating endothelial cells. J Cell Biol 122:673-684.
Seghezzi G., Marelli R., Mandriota S.J., Nolli M.L., Mazzieri R., Mignatti P. (1996) Tumor cell-conditioned medium stimulates expression of the urokinase receptor in vascular endothelial cells. J Cell Physiol 169:300-308.
Planus E., Barlovatz-Meimon G., Rogers R.A., Bonavaud S., Ingber D.E., Wang N. (1997) Binding of urokinase to plasminogen activator inhibitor type-1 mediates cell adhesion and spreading. J Cell Sci 110:1091-1098.
Sandberg T., Casslen B., Gustavsson B., Benraad T.J. (1998) Human endothelial cell migration is stimulated by urokinase plasminogen activator: Plasminogen activator inhibitor 1 complex released from endometrial stromal cells stimulated with transforming growth factor β1; possible mechanism for paracrine stimulation of endometrial angiogenesis. Biol Reprod 59:759-767.